The Infection Surveillance Solutions Market Size is valued at USD 544.93 Mn in 2022 and is predicted to reach USD 1581.37 Mn by the year 2031 at a 12.7 % CAGR during the forecast period for 2023-2031.
The term "infection surveillance solutions" refers to systems continuously tracking and managing information on healthcare-associated infections (HAIs) for public health evaluation. The effective implementation of preventative interventions depends on the early recognition of sickness. The two main factors pushing the growth of the infection surveillance solutions systems market are the rise in microbial resistance to antibiotics and the increased usage of automation in healthcare settings.
The rise in hospital-associated illnesses, such as urinary tract infections, surgical site infections, and poor sanitation, drives the market for infection surveillance solutions. Furthermore, The rise in the practice of self-medication, the expansion of IT systems' analytical processing capabilities, and non-adherence to prescribed medication all impact the market for infection surveillance systems.
Additionally, the market for infection surveillance solutions is positively impacted by government initiatives in the form of policies, an increase in healthcare spending, an increase in the number of surgeries, and research and development activities. On the other hand, the market expansion for infection surveillance solutions is anticipated to be hampered by the high cost of the software, medical professionals' resistance to utilizing cutting-edge healthcare products, and a shortage of operating skilled it professionals.
The infection surveillance solutions market is segmented on the basis of products & services, and End-User. Based on the product & services, the segmentation is as software which includes on-premise and web-based software and up to 50 hp, which consists of product support & maintenance services, implementation services and training & consulting services). Based on End-User, the market segments are hospitals (large, medium-sized hospitals, and small hospitals), long-term care facilities (nursing homes, skilled nursing facilities and assisted-living facilities), and other end users.
The software category will hold a major share of the global market in 2022. Technology development has contributed to this rise by enabling efficient patient data management, research, and comprehension. Elation Health is a cloud-based, clinically focused solution for doctors looking for an ONC-ATCB-approved electronic medical record (EMR), including patient appointments, a patient portal, e-prescribing, and e-faxing. Electronic medical records are progressively being utilized as part of the software segment because of the benefits the cloud provides, such as cheaper maintenance costs, enhanced collaboration, good backup and restore data capabilities, and more convenience.
The segment, hospital, is estimated to grow rapidly in the global infection surveillance solutions market. Hospitals have significant purchasing power, and their involvement in the system-building process has contributed to their dominance. In addition, hospitals have stronger HAI management skills and can monitor patients within the allotted period. Over 45% of hospitals are thought to use software and surveillance systems for speedier illness analysis. They installed automated technologies to examine historical infection patterns through simulation, aiding in the containment of healthcare-acquired illnesses in healthcare institutions.
The North American infection surveillance solutions market is expected to record the major market share in revenue. The stricter regulations and the substantial number of companies providing infection surveillance solutions in North America are driving factors in the market for these products. The prevalence of HAIs in the U.S. and Canada is on the rise, and this, combined with strong government measures, is anticipated to fuel regional market expansion.
To tackle germs that are resistant to antibiotics, such as the prevalence of Clostridium difficile, Carbapenem-resistant Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus, the National Action Plan (NAP), a five-year action plan, was introduced. In addition, Asia-Pacific is expected to grow at the quickest rate. The primary forces in the area are the growing public awareness of health issues, rising healthcare spending, increased healthcare facilities, and quick advancements in health insurance.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 544.93 Mn |
| Revenue Forecast In 2031 | USD 1581.37 Mn |
| Growth Rate CAGR | CAGR of 12.7 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product & Services, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Becton, Dickinson and Company (US), Premier, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Clinisys (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), Merative (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab (US), Harris Healthcare (US), PeraHealth (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and VIZZIA Technologies (US). |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Infection Surveillance Solutions Market By Product & Services
Infection Surveillance Solutions Market By End User
Infection Surveillance Solutions Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.